Transabdominal ultrasound (TAUS) demonstrated an 85.7% detection rate for cystic pancreatic lesions, which was also noted with endoscopic US (EUS), with BMI and lesion size significantly affecting the ...

FRIDAY, Nov. 14, 2025 (HealthDay News) — Pancreatic cancer is known as a silent killer, showing few symptoms until it reaches ...

Laparoscopy and laparoscopic ultrasound have been validated previously as staging tools for pancreatic cancer. The aim of this study was to identify if assessment of vascular involvement with ...

A team of providers from Morgantown, W.Va.-based WVU Medicine became the first in the U.S. to treat a pancreatic lesion using endoscopic ultrasound-guided microwave ablation.  Led by Shailendra Singh, ...

Pancreatic cancer is often called a silent killer because it shows a few symptoms until it progresses to fatal stages.

Please provide your email address to receive an email when new articles are posted on . AI model demonstrated 94% accuracy in discerning cystic pancreatic focal lesions from solid lesions in ...

Ultrasound is a promising technique for treating cancer. Unlike laser light, used in photodynamic cancer therapy, ultrasound waves can reach deep into tissue - up to 12 cm - to treat deep tumors ...

Endoscopic ultrasound (EUS) is an accurate modality for the diagnosis and staging of pancreatic cancer. The ability of EUS to predict the absence of pancreatic cancer in individuals suspected to have ...

A new study from Johns Hopkins Medicine has found that even a small enlargement of the pancreatic duct — the tiny tube that ...

NEW HAVEN — Patients suffering pain and jaundice from blocked bile ducts can find relief without going through major surgery, with the use of endoscopic ultrasound, according to the director of the ...

A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved ...

Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin. EUS ...